Ebanga

Active Ingredient(s): Ansuvimab-zykl
FDA Approved: * December 21, 2020
Pharm Company: * RIDGEBACK BIOTHERAPEUTICS
Category: Antiviral

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Ebanga Overview

Ansuvimab, sold under the brand name Ebanga, is a monoclonal antibody medication for the treatment of Zaire ebolavirus (Ebolavirus) infection.[1][2] The most common symptoms include fever, tachycardia (fast heart rate), diarrhea, vomiting, hypotension (low blood pressure), tachypnea (fast breathing) and chills; however, these are also common symptoms of Ebolavirus infection.[1] Ansuvimab was approved for medical use in the United States in Decem...

Read more Ebanga Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ansuvimab

Recent Ebanga Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Ansuvimab-zykl
  • Powder: 400mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Ansuvimab-zykl or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 4 August 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA